ask="6.9700"
ask_size="100"
average_daily_volume="31074"
bid="4.9000"
bid_size="100"
book_value="1.8080"
change="+0.0199"
change_from_200_day_moving_average="-0.3718"
change_from_50_day_moving_average="0.0470"
change_from_52_week_high="-4.1101"
change_From_52_week_low="0.6999"
change_in_percent="+0.3119%"
close="6.3999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.8600"
ebitda="-9.95M"
eps_estimate_current_year="-0.6200"
eps_estimate_next_quarter="-0.1700"
eps_estimate_next_year="-1.0100"
ex_dividend_date="N/A"
float_shares="8775000"
high="6.4426"
high_52_weeks="10.5100"
last_trade_date="2/21/2017"
last_trade_price="6.3999"
last_trade_size="100"
last_trade_time="3:37pm"
low="6.3200"
low_52_weeks="5.7000"
market_capitalization="85.01M"
moving_average_200_day="6.7717"
moving_average_50_day="6.3529"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.0000"
open="6.3500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-5.4904%"
percent_change_from_50_day_moving_average="+0.7392%"
percent_change_from_52_week_high="-39.1066%"
percent_change_from_52_week_low="+12.2789%"
previous_close="6.3800"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.5288"
price_per_sales="67.7422"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="11.9700"
stock_exchange="NCM"
symbol="ORMP"
volume="18273"
weeks_range_52="5.7000 - 10.5100"
